pk 11195 has been researched along with Lymphoma, B-Cell in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muscarella, DE | 1 |
| O'Brien, KA | 1 |
| Lemley, AT | 1 |
| Bloom, SE | 1 |
1 other study available for pk 11195 and Lymphoma, B-Cell
| Article | Year |
|---|---|
Reversal of Bcl-2-mediated resistance of the EW36 human B-cell lymphoma cell line to arsenite- and pesticide-induced apoptosis by PK11195, a ligand of the mitochondrial benzodiazepine receptor.
Topics: Antineoplastic Agents; Apoptosis; Arsenites; Benzimidazoles; Cell Line, Tumor; Drug Resistance, Neop | 2003 |